Freenome, a company specializing in early cancer detection through blood-based screening tests, announced it will release its financial results for the third quarter ending September 30, 2026, on November 10 after market close. The company will hold a conference call to discuss these results shortly after the release. Freenome's technology focuses on detecting cancer early by analyzing DNA methylation patterns and other biomarkers, aiming to improve cancer screening for diseases like colorectal and lung cancer. Investors can access the live webcast and archived recordings on Freenome's investor relations website.
Freenome's upcoming Q3 2026 financial results are scheduled for release on November 10, 2026. For readers following the health sector, here is Pluang's market snapshot as of Oct 16, 2026 03:21 WIB: out of 150 priced health-sector US stocks, 128 rose and 21 fell. Notable movers include HIMS at USD 29.30 with a 5.70% increase, COGT at USD 29.64 up 5.29%, and DXCM at USD 87.67 rising 5.03%.
Regions Financial is set to report its Q3 2026 earnings with expected EPS around $0.66 and revenue near $2 billion. The bank anticipates a 2% rise in net interest income and a 2.2% increase in fee income, but expects a 12.3% drop in capital markets r...
Pepeto's latest presale stage is close to selling out, raising $10.845 million with three products live and a Binance listing expected. This surge coincides with XRP maintaining its $1.30-$1.43 range and a bold $315 price prediction fueled by strong ...
Prologis reported Q3 2026 revenue of $2.39 billion and core FFO of $1.60 per share, surpassing analyst estimates due to high demand from e-commerce, manufacturing, and data centers. Leasing activity remained robust with 95.6% occupancy and 60 million...
HDFC Bank is set to announce its quarterly earnings on October 17, 2026, with analysts expecting $0.40 earnings per share and $4.92 billion in revenue. The bank's valuation shows a trailing earnings multiple of 14.45x and a debt-to-equity ratio of 0....
Kohl's Chief Legal and Corporate Affairs Officer Jennifer J. Kent sold 18,352 shares for $403,744 on October 15, 2026, reducing her stake to 211,512 shares. Market opinions on Kohl's stock are divided, with some analysts expecting a decline while oth...
